How Much Upside is Left in SpringWorks Therapeutics (SWTX)? Wall Street Analysts Think 77.9%

SpringWorks Therapeutics (SWTX) closed the last trading session at $36.96, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $65.75 indicates a 77.9% upside potential. The mean estimate comprises eight short-term price targets with a standard deviation of $8.81. While the lowest estimate of $52 indicates a 40.7% increase from the current price level, the most optimistic ...